In this fast-paced online economy, deals are a dime a dozen. I typically don't pay attention to them. I just don't have enough money for all the deals, all right? But every so often, there's a deal ...
SYDNEY--Vaccine and blood-products giant CSL plans to cut up to 15% of staff and spin off its Seqirus business as part of a restructuring plan costing up to $770 million. The Australia-listed company ...
SYDNEY--Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.
SYDNEY--Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results